Products

GoAiMEX

AI-native

Trade Globally. Zero Compliance Headaches.

goaimex.com Legal & Compliance / Compliance Automation

Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$20/mo
Lower than 79% of peersNiche median $49/mo
Creators
Unlinked
No verified creators
Launched
12mo ago
2025-12-08 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Turn 12 hours of export paperwork into 30 minutes with AI

    Dec 8, 2025 · 12mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered 2025-11-11

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Single User
$30/mo
Unlimited Policy Lookups · Unlimited Workflows · 1 User
Team
$20/mo
3+ Users

Trial: None · 2 paid tiers ($20–$30) · Observed 2026-11-06 · Source page

Entry price $20/mo, Lower than 79% of peers; “Compliance Automation” median is $49/mo.View pricing benchmark

Website snapshots

Indexed 2025-12-08

Key pages

Desktop & mobile archive
Home
www.goaimex.com/ Snapshot 2026-11-07

Questions & evidence

How much does GoAiMEX cost?
Single User: $30/mo; Team: $20/mo. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does GoAiMEX get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is GoAiMEX and what platforms does it support?
GoAiMEX is catalogued under Compliance Automation: Trade Globally. Zero Compliance Headaches. Supported platforms: Web.

Related products in this category

Legal & Compliance / Compliance Automation

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.